Literature DB >> 7818634

Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission.

G Andersen1, M Ingeman-Nielsen, K Vestergaard, J O Riis.   

Abstract

BACKGROUND AND
PURPOSE: The aim of the study was to correlate the severity of poststroke pathological crying with lesion size and location.
METHODS: Twelve selected stroke patients were ranked in terms of overall clinical severity of the syndrome of pathological crying, and the size and location of the stroke lesion(s) were determined by magnetic resonance imaging.
RESULTS: The patients with the clinically most severe pathological crying had relatively large bilateral pontine lesions without lesions in the hemispheres. The intermediate group had bilateral central hemispheric lesions, and the clinically least affected patients had mainly unilateral large subcortical lesions.
CONCLUSIONS: Poststroke pathological crying may be attributable to stroke-induced partial destruction of the serotonergic raphe nuclei in the brain stem or their ascending projections to the hemispheres.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7818634     DOI: 10.1161/01.str.25.5.1050

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  15 in total

1.  Abnormal pontine activation in pathological laughing as shown by functional magnetic resonance imaging.

Authors:  H Kosaka; N Omata; M Omori; T Shimoyama; T Murata; K Kashikura; T Takahashi; J Murayama; Y Yonekura; Y Wada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12       Impact factor: 10.154

Review 2.  Pathological laughing and crying : epidemiology, pathophysiology and treatment.

Authors:  Hal S Wortzel; Timothy J Oster; C Alan Anderson; David B Arciniegas
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 3.  Treatment of uncontrolled crying after stroke.

Authors:  G Andersen
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

Review 4.  Current concepts in the pharmacotherapy of pseudobulbar affect.

Authors:  Erik P Pioro
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

5.  Association of Lesion Location and Fatigue Symptoms After Ischemic Stroke: A VLSM Study.

Authors:  Jinjing Wang; Mengmeng Gu; Lulu Xiao; Shiyi Jiang; Dawei Yin; Ye He; Peng Wang; Wen Sun; Xinfeng Liu
Journal:  Front Aging Neurosci       Date:  2022-06-29       Impact factor: 5.702

6.  The causes and treatment of pseudobulbar affect in ischemic stroke.

Authors:  Preethi Balakrishnan; Howard Rosen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-06

Review 7.  Oscillatory serotonin function in depression.

Authors:  Ronald M Salomon; Ronald L Cowan
Journal:  Synapse       Date:  2013-05-21       Impact factor: 2.562

Review 8.  Dextromethorphan/quinidine sulfate for pseudobulbar affect.

Authors:  Howard Rosen
Journal:  Drugs Today (Barc)       Date:  2008-09       Impact factor: 2.245

9.  Prevalence and clinical correlates of pathological affective display in Alzheimer's disease.

Authors:  S E Starkstein; R Migliorelli; A Tesón; G Petracca; E Chemerinsky; F Manes; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

10.  Pain following stroke: a population-based follow-up study.

Authors:  Henriette Klit; Nanna B Finnerup; Kim Overvad; Grethe Andersen; Troels S Jensen
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.